| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $53,028,995 ) (Continued on the next page) |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL105924 | Thrombospondin 4 regulates adaptive ER stress responseRenewal - Resubmission - 1 | 000 | 15 | NIH | 2/24/2026 | $566,138 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD110321 | Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department | 000 | 4 | NIH | 4/2/2026 | $769,815 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD114702 | Food-based Randomized trial for Enhancing Support of Hospitalized children and their families (FRESH) | 001 | 2 | NIH | 3/26/2026 | $67,300 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD113529 | A Multisite RCT of a Daily Living Skills Intervention for Autistic Adolescents Prior to the Transition to Adulthood | 000 | 3 | NIH | 3/23/2026 | $648,898 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD114702 | Food-based Randomized trial for Enhancing Support of Hospitalized children and their families (FRESH) | 000 | 2 | NIH | 1/16/2026 | $605,702 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK132408 | Precise Infliximab Exposure and Pharmacodynamic Control to Achieve Deep Remission in Pediatric Crohn's Disease | 000 | 5 | NIH | 3/19/2026 | $655,158 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK133198 | Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease | 000 | 5 | NIH | 3/6/2026 | $569,533 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK133145 | Diabetic Memory in Hematopoietic Stem Cells | 000 | 4 | NIH | 12/22/2025 | $436,663 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK145648 | From real-world evidence to systems pharmacology: a comprehensive approach to drug-induced pancreatic injury | 000 | 1 | NIH | 3/24/2026 | $824,078 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK146438 | Mechanisms regulating competency of hepatocyte plasticity | 000 | 1 | NIH | 2/10/2026 | $851,275 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK134646 | RNA silencing machinery in extracellular vesicle-mediated immunometabolic regulation | 000 | 3 | NIH | 1/15/2026 | $584,778 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK135478 | Organoid-guided Precision Hepatology for Steatohepatitis | 000 | 3 | NIH | 1/14/2026 | $589,780 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK095001 | Genetic and microenvironmental regulation of macrophage functions driving biliary fibrosis in pediatric PSC | 000 | 11 | NIH | 2/19/2026 | $533,386 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DE033890 | Molecular Regulation of Palate Development | 000 | 3 | NIH | 12/17/2025 | $589,163 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA271455 | Dissecting innate immune signaling in pre-leukemia evolution | 000 | 5 | NIH | 3/2/2026 | $638,243 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA278834 | The role of DNAJB1-PKAc-β-catenin axis in fibrolamellar HCC | 000 | 4 | NIH | 3/24/2026 | $622,939 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA278756 | Rational targeting of Cdc42 to benefit immunotherapy | 000 | 3 | NIH | 12/8/2025 | $534,962 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35GM149328 | Signaling dynamics in the control of ectoderm patterning and morphogenesis | 001 | 4 | NIH | 2/17/2026 | $405,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 006 | 4 | NIH | 4/2/2026 | -$680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 005 | 4 | NIH | 3/31/2026 | -$135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 004 | 4 | NIH | 3/31/2026 | -$62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 003 | 4 | NIH | 2/24/2026 | $135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 002 | 4 | NIH | 2/23/2026 | $62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 001 | 4 | NIH | 2/20/2026 | $680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 000 | 4 | NIH | 2/17/2026 | $643,153 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21CA300922 | Pancancer discovery and exploration of shared splicing neoantigens | 000 | 2 | NIH | 2/27/2026 | $187,584 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21HD118147 | Neural Crest Regulation of Embryonic Calcium Uptake | 000 | 2 | NIH | 2/26/2026 | $240,750 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21AI183058 | Systems analysis of immune responses to Norovirus infection in a human challenge model. | 000 | 2 | NIH | 12/5/2025 | $200,625 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21AI191085 | Development and application of pediatric-specific blood transcriptional modules across diverse geographical settings through public data mining | 000 | 2 | NIH | 4/1/2026 | $160,264 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS140460 | Glial Origin and Signaling in Medulloblastoma | 001 | 2 | NIH | 2/28/2026 | $60,484 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS140460 | Glial Origin and Signaling in Medulloblastoma | 000 | 2 | NIH | 1/30/2026 | $544,368 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS105715 | Sensitization of developing sensory neurons after incision | 000 | 8 | NIH | 3/31/2026 | $413,504 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS132504 | Advancing CNS drug delivery via epigenetic modulation | 001 | 4 | NIH | 3/20/2026 | $56,853 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS132504 | Advancing CNS drug delivery via epigenetic modulation | 000 | 4 | NIH | 1/31/2026 | $511,676 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS124660 | Roles of Gsx factors in basal ganglia development | 000 | 5 | NIH | 1/30/2026 | $542,324 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS125316 | Understanding the Impact of Youth Onset Obesity and Type 2 Diabetes on the Neurovascular Unit | 000 | 5 | NIH | 3/19/2026 | $372,200 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS125316 | Understanding the Impact of Youth Onset Obesity and Type 2 Diabetes on the Neurovascular Unit | 000 | 5 | NIH | 3/19/2026 | $78,949 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS120892 | Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors | 000 | 5 | NIH | 2/24/2026 | $500,637 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS124660 | Roles of Gsx factors in basal ganglia development | 001 | 5 | NIH | 2/28/2026 | $60,259 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS094200 | A New Model to Identify Preterm Neonates at High-Risk for Cognitive Impairments and School Readiness | 000 | 11 | NIH | 3/19/2026 | $826,976 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS028840 | Mitogenic Activities in Neurofibromatosis | 000 | 34 | NIH | 3/31/2026 | $607,383 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01MH139504 | Impact of Circadian Misalignment for Adolescents with ADHD: Observational and Mechanistic Data | 000 | 1 | NIH | 3/5/2026 | $820,196 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171046 | Initiators of thrombotic microangiopathy | 001 | 3 | NIH | 3/24/2026 | $20,175 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171221 | Developing DWORF gene therapy to treat heart failure and muscular dystrophy | 001 | 3 | NIH | 3/30/2026 | $17,815 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171046 | Initiators of thrombotic microangiopathy | 000 | 3 | NIH | 2/9/2026 | $638,913 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171221 | Developing DWORF gene therapy to treat heart failure and muscular dystrophy | 000 | 3 | NIH | 2/23/2026 | $564,156 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167700 | Pathogenesis of Vascular Anomalies with GNAQ mutations | 000 | 3 | NIH | 3/23/2026 | $581,713 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167200 | Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells | 001 | 4 | NIH | 3/13/2026 | $19,879 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167200 | Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells | 000 | 4 | NIH | 2/16/2026 | $629,508 |
|
